| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
HC Wainwright & Co. analyst Swayampakula Ramakanth assumes Dyadic International (NASDAQ:DYAI) with a Buy rating and anno...
Dyadic International (NASDAQ:DYAI) reported quarterly losses of $(0.06) per share which met the analyst consensus estimate. Thi...
Dyadic International, Inc. ("Dyadic" or the "Company") (NASDAQ:DYAI), a global biotechnology company focused on...